T1	GGPs 36 45	TNF-alpha
T2	GGPs 665 667	IL
T3	Localization 1064 1071	release
T5	GGPs 705 713	IL-12p40
T8	Disorder 909 920	sarcoidosis
T9	Disorder 860 889	idiopathic pulmonary fibrosis
T10	Localization 46 53	release
T15	GGPs 608 639	transforming growth factor-beta
T16	GGPs 1623 1640	interleukin-12p40
T17	Disorder 815 843	hypersensitivity pneumonitis
T18	GGPs 1058 1063	IL-18
T19	Disorder 1518 1546	hypersensitivity pneumonitis
T20	GGPs 695 703	IL-12p70
T21	GGPs 1249 1254	IL-18
T22	Subject 928 936	patients
T23	GGPs 1642 1656	interleukin-18
T27	Subject 1183 1191	patients
T28	GGPs 676 680	IL-6
T29	Disorder 1505 1516	sarcoidosis
T30	Disorder 892 895	IPF
T32	Disorder 435 460	interstitial lung disease
T34	GGPs 688 693	IL-10
T35	GGPs 652 663	interleukin
T36	Artificial_process 238 247	treatment
T37	Cell 59 79	alveolar macrophages
T40	Disorder 1551 1580	idiopathic pulmonary fibrosis
T41	GGPs 682 686	IL-8
T42	GGPs 1259 1263	IL-8
T43	Disorder 793 804	sarcoidosis
T45	GGPs 20 25	IL-18
T46	Pharmacological_substance 1407 1418	thalidomide
T50	GGPs 641 650	TNF-alpha
T52	GGPs 1045 1053	IL-12p40
T55	Organic_compound_other 1317 1320	LPS
T57	GGPs 718 723	IL-18
T58	Organic_compound_other 1124 1127	LPS
T61	GGPs 1239 1247	IL-12p40
T62	Biological_process 170 186	immunomodulation
T65	GGPs 27 31	IL-8
T67	Subject 1302 1310	patients
T69	Disorder 1179 1182	IPF
T70	Disorder 1283 1294	sarcoidosis
T73	Positive_regulation 1321 1332	stimulation
T74	GGPs 1337 1346	cytokines
T75	GGPs 343 346;347 353	TNF -alpha
T78	Disorder 83 108	interstitial lung disease
T80	GGPs 1228 1237	TNF-alpha
T81	Disorder 251 262	sarcoidosis
T82	Organic_compound_other 1018 1021	LPS
T83	Artificial_process 1480 1500	therapeutic regimens
T85	GGPs 1034 1043	TNF-alpha
T86	GGPs 1593 1621	tumour necrosis factor-alpha
T87	GGPs 319 341;347 353	tumour necrosis factor -alpha
T89	Disorder 268 280	lupus pernio
T90	Cell 727 747	alveolar macrophages
T91	Pharmacological_substance 111 122	Thalidomide
E1	Localization:T3 Theme:T85
E3	Localization:T10 fromLoc:T37 Theme:T1
E6	Artificial_process:T36 Instrument:T48 Theme:T81
E7	Biological_process:T62 
E8	Positive_regulation:T73 Cause:T55 Theme:E28
E9	Artificial_process:T83 Instrument:T103 disorder2:T19 disorder3:T40 disorder:T29
N4	Reference T1 UMLS:C1456820	Tumor Necrosis Factor-alpha
N8	Reference T2 UMLS:C1527200	Recombinant Interleukins
N9	Reference T2 UMLS:C0021764	Interleukins
N23	Reference T5 UMLS:C1099914	IL12B protein, human
N35	Reference T9 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N70	Reference T18 UMLS:C3849701	interleukin 18 protein, human
N79	Reference T21 UMLS:C3849701	interleukin 18 protein, human
N81	Reference T22 UMLS:C0030705	Patients
N84	Reference T23 UMLS:C3849701	interleukin 18 protein, human
N103	Reference T27 UMLS:C0030705	Patients
N108	Reference T28 UMLS:C1698754	IL6 protein, human
N112	Reference T29 UMLS:C0036202	Sarcoidosis
N116	Reference T30 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N124	Reference T32 UMLS:C0206062	Lung Diseases, Interstitial
N130	Reference T34 UMLS:C1699802	IL10 protein, human
N136	Reference T35 UMLS:C0021764	Interleukins
N146	Reference E6 UMLS:C0087111	Therapeutic procedure
N150	Reference T37 UMLS:C0085236	Macrophages, Alveolar
N156	Reference T40 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N161	Reference T41 UMLS:C1698756	CXCL8 protein, human
N164	Reference T42 UMLS:C1698756	CXCL8 protein, human
N166	Reference T43 UMLS:C0036202	Sarcoidosis
N172	Reference T45 UMLS:C3849701	interleukin 18 protein, human
N175	Reference T46 UMLS:C0039736	Thalidomide
N189	Reference T50 UMLS:C1456820	Tumor Necrosis Factor-alpha
N195	Reference T52 UMLS:C1099914	IL12B protein, human
N207	Reference T55 UMLS:C0023810	Lipopolysaccharides
N215	Reference T57 UMLS:C3849701	interleukin 18 protein, human
N229	Reference T61 UMLS:C1099914	IL12B protein, human
N244	Reference T65 UMLS:C1698756	CXCL8 protein, human
N247	Reference T67 UMLS:C0030705	Patients
N254	Reference T69 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N258	Reference T70 UMLS:C0036202	Sarcoidosis
N280	Reference T78 UMLS:C0206062	Lung Diseases, Interstitial
N287	Reference T80 UMLS:C1456820	Tumor Necrosis Factor-alpha
N291	Reference T81 UMLS:C0036202	Sarcoidosis
N308	Reference T85 UMLS:C1456820	Tumor Necrosis Factor-alpha
N322	Reference T90 UMLS:C0085236	Macrophages, Alveolar
N325	Reference T91 UMLS:C0039736	Thalidomide
T92	Pharmacological_substance 0 11	Thalidomide
N1	Reference T92 UMLS:C0039736	Thalidomide
T93	Negative_regulation 12 19	reduces
E11	Negative_regulation:T93 Cause:T92 Theme:E3
E12	Localization:T10 Theme:T65 fromLoc:T37
E13	Localization:T10 Theme:T45 fromLoc:T37
E14	Negative_regulation:T93 Theme:E12 Cause:T92
E15	Negative_regulation:T93 Theme:E13 Cause:T92
T63	Positive_regulation 140 147	actions
E16	Positive_regulation:T63 Cause:T91 Theme:E19
N7	Reference E7 UMLS:C1963758	Immunomodulation
T44	Biological_process 151 168	anti-inflammation
E19	Biological_process:T44 
E17	Positive_regulation:T63 Cause:T91 Theme:E7
E20	Positive_regulation:T63 Cause:T91 Theme:E22
T94	Biological_process 191 208	anti-angiogenesis
E22	Biological_process:T94 
T48	Pharmacological_substance 226 237	thalidomide
T88	Negative_regulation 305 315	inhibition
E10	Negative_regulation:T88 Theme:T87 Cause:T48
T96	Pharmacological_substance 402 413	thalidomide
T97	Molecular_function 359 369	mechanisms
E24	Molecular_function:T97 Cause:T96 disorder:T32
N5	Reference E24 UMLS:C0441712	Mechanism (attribute)
T11	Subject 806 812	n  = 8
A5	Count_sbjct T11
A6	Organism_sbjct T11 Human
A7	Patient_sbjct T11 Patient
R3	Subject_Disorder Arg1:T11 Arg2:T43	
T76	Disorder 845 847	HP
T98	Subject 849 854	n = 8
R5	Subject_Disorder Arg1:T98 Arg2:T76	
T53	Pharmacological_substance 531 542	thalidomide
T68	GGPs 665 667;668 674	IL -1beta
T99	Subject 897 903	n = 12
R7	Subject_Disorder Arg1:T99 Arg2:T9	
A8	Count_sbjct T99
A9	Organism_sbjct T99 Human
A10	Patient_sbjct T99 Patient
A11	Count_sbjct T98
A12	Organism_sbjct T98 Human
A13	Patient_sbjct T98 Patient
T100	Disorder 925 927	HP
T101	Pharmacological_substance 938 949	thalidomide
T102	Positive_regulation 950 957	induced
E25	Positive_regulation:T102 Cause:T101 Theme:E51
T6	Organic_compound_other 999 1016	lipopolysacchride
T103	Pharmacological_substance 1435 1446	thalidomide
T13	GGPs 1661 1674	interleukin-8
T38	Positive_regulation 1023 1033	stimulated
E2	Positive_regulation:T38 Cause:T6 Theme:E49
T104	Negative_regulation 1584 1592	reducing
E26	Negative_regulation:T104 Theme:E4 Cause:T103
T39	Negative_regulation 1394 1403	inhibited
E27	Negative_regulation:T39 Cause:T46 Theme:E78
T47	Positive_regulation 1366 1374	elevated
E28	Positive_regulation:T47 Theme:E5
E29	Gene_expression:T72 Theme:T57 atLoc:T90
T7	Negative_regulation 509 527	inhibitory effects
E30	Negative_regulation:T7 Cause:T53 Theme:E37
E31	Gene_expression:T72 Theme:T5 atLoc:T90
E32	Gene_expression:T72 Theme:T20 atLoc:T90
E33	Gene_expression:T72 Theme:T34 atLoc:T90
E34	Gene_expression:T72 Theme:T41 atLoc:T90
E35	Gene_expression:T72 Theme:T28 atLoc:T90
E36	Gene_expression:T72 Theme:T68 atLoc:T90
E37	Gene_expression:T72 Theme:T50 atLoc:T90
E38	Gene_expression:T72 Theme:T15 atLoc:T90
E39	Negative_regulation:T7 Cause:T53 Theme:E38
E40	Negative_regulation:T7 Cause:T53 Theme:E36
E41	Negative_regulation:T7 Cause:T53 Theme:E35
E42	Negative_regulation:T7 Cause:T53 Theme:E29
E43	Negative_regulation:T7 Cause:T53 Theme:E34
E44	Negative_regulation:T7 Cause:T53 Theme:E33
E45	Negative_regulation:T7 Cause:T53 Theme:E32
E46	Negative_regulation:T7 Cause:T53 Theme:E31
T56	Subject 928 936	patients
R9	Subject_Disorder Arg1:T56 Arg2:T8	
R10	Subject_Disorder Arg1:T22 Arg2:T100	
E47	Positive_regulation:T38 Cause:T6 Theme:E50
E48	Positive_regulation:T38 Cause:T6 Theme:E1
E49	Localization:T3 Theme:T18
E50	Localization:T3 Theme:T52
T49	Negative_regulation 984 995	suppression
E51	Negative_regulation:T49 Theme:E1 disorder:T8 disorder2:T100
E52	Positive_regulation:T102 Cause:T101 Theme:E54
E53	Positive_regulation:T102 Cause:T101 Theme:E55
E54	Negative_regulation:T49 Theme:E49 disorder:T8 disorder2:T100
E55	Negative_regulation:T49 Theme:E50 disorder:T8 disorder2:T100
T25	Pharmacological_substance 1088 1099	thalidomide
T54	Positive_regulation 1128 1138	stimulated
E56	Positive_regulation:T54 Cause:T58 Theme:E57
T66	GGPs 1139 1143	IL-8
T110	Gene_expression 1144 1154	production
E57	Gene_expression:T110 Theme:T66
T111	Negative_regulation 1164 1174	suppressed
E58	Negative_regulation:T111 Cause:T25 Theme:E57
R11	Subject_Disorder Arg1:T27 Arg2:T69	
T112	Disorder 1299 1301	HP
T113	Subject 1302 1310	patients
R12	Subject_Disorder Arg1:T113 Arg2:T70	
R13	Subject_Disorder Arg1:T67 Arg2:T112	
A20	Organism_sbjct T27 Human
A21	Patient_sbjct T27 Patient
A22	Organism_sbjct T113 Human
A23	Patient_sbjct T113 Patient
A24	Organism_sbjct T67 Human
A25	Patient_sbjct T67 Patient
R14	member_of Arg1:T80 Arg2:T74	
R15	member_of Arg1:T61 Arg2:T74	
R16	member_of Arg1:T21 Arg2:T74	
R17	member_of Arg1:T42 Arg2:T74	
E60	Gene_expression:T51 Theme:T21 atLoc:T27
E61	Gene_expression:T33 Theme:T42 atLoc:T27
E62	Gene_expression:T60 Theme:T61 atLoc:T27
E63	Gene_expression:T33 Theme:T80 atLoc:T27
N27	Reference E9 UMLS:C1276413	Therapeutic regimen
E4	Gene_expression:T31 Theme:T13
E64	Gene_expression:T79 Theme:T23
E65	Gene_expression:T77 Theme:T16
E66	Gene_expression:T31 Theme:T86
E67	Negative_regulation:T104 Theme:E64 Cause:T103
E68	Negative_regulation:T104 Theme:E65 Cause:T103
E69	Negative_regulation:T104 Theme:E66 Cause:T103
N3	Reference T48 UMLS:C0039736	Thalidomide
N28	Reference T89 UMLS:C1141942	Lupus pericarditis
N29	Reference T87 UMLS:C1456820	Tumor Necrosis Factor-alpha
N30	Reference T75 UMLS:C1456820	Tumor Necrosis Factor-alpha
N33	Reference T96 UMLS:C0039736	Thalidomide
N34	Reference T53 UMLS:C0039736	Thalidomide
N39	Reference T15 UMLS:C0040690	Transforming Growth Factor beta
N40	Reference T20 UMLS:C1701815	IL12A protein, human
N31	Reference T8 UMLS:C0036202	Sarcoidosis
A28	Organism_sbjct T22 Human
A29	Patient_sbjct T22 Patient
A30	Organism_sbjct T56 Human
A31	Patient_sbjct T56 Patient
N36	Reference T101 UMLS:C0039736	Thalidomide
N42	Reference T103 UMLS:C0039736	Thalidomide
N43	Reference T25 UMLS:C0039736	Thalidomide
N44	Reference T6 UMLS:C0023810	Lipopolysaccharides
N45	Reference T82 UMLS:C0023810	Lipopolysaccharides
N46	Reference T58 UMLS:C0023810	Lipopolysaccharides
N47	Reference T66 UMLS:C1698756	CXCL8 protein, human
N51	Reference T86 UMLS:C1456820	Tumor Necrosis Factor-alpha
N52	Reference T16 UMLS:C1099914	IL12B protein, human
N6	Reference T13 UMLS:C1698756	CXCL8 protein, human
N48	Reference T74 UMLS:C0079189	cytokine
N24	Reference T17 UMLS:C0002390	Extrinsic allergic alveolitis
N41	Reference T76 UMLS:C0002390	Extrinsic allergic alveolitis
N32	Reference T100 UMLS:C0002390	Extrinsic allergic alveolitis
N49	Reference T112 UMLS:C0002390	Extrinsic allergic alveolitis
N50	Reference T19 UMLS:C0002390	Extrinsic allergic alveolitis
N37	Reference T68 UMLS:C1702300	IL1B protein, human
N61	Reference E15 UMLS:C3463820	Inhibition
N62	Reference E14 UMLS:C3463820	Inhibition
N63	Reference E11 UMLS:C3463820	Inhibition
N65	Reference E42 UMLS:C3463820	Inhibition
N66	Reference E46 UMLS:C3463820	Inhibition
N67	Reference E45 UMLS:C3463820	Inhibition
N68	Reference E44 UMLS:C3463820	Inhibition
N69	Reference E43 UMLS:C3463820	Inhibition
N71	Reference E41 UMLS:C3463820	Inhibition
N72	Reference E40 UMLS:C3463820	Inhibition
N11	Reference E30 UMLS:C3463820	Inhibition
N73	Reference E39 UMLS:C3463820	Inhibition
N74	Reference E51 UMLS:C3463820	Inhibition
N75	Reference E55 UMLS:C3463820	Inhibition
N76	Reference E54 UMLS:C3463820	Inhibition
N77	Reference E58 UMLS:C3463820	Inhibition
N10	Reference E27 UMLS:C3463820	Inhibition
N78	Reference E69 UMLS:C3463820	Inhibition
N80	Reference E68 UMLS:C3463820	Inhibition
N82	Reference E67 UMLS:C3463820	Inhibition
N83	Reference E26 UMLS:C3463820	Inhibition
N85	Reference E20 UMLS:C1879547	Activation
N2	Reference E16 UMLS:C1879547	Activation
N88	Reference E25 UMLS:C1879547	Activation
N89	Reference E53 UMLS:C1879547	Activation
N90	Reference E52 UMLS:C1879547	Activation
N91	Reference E48 UMLS:C1879547	Activation
N92	Reference E47 UMLS:C1879547	Activation
N93	Reference E2 UMLS:C1879547	Activation
N95	Reference E10 UMLS:C3463820	Inhibition
N96	Reference E28 UMLS:C1879547	Activation
N97	Reference E8 UMLS:C1879547	Activation
N98	Reference E56 UMLS:C1879547	Activation
T71	Subject 83 108	interstitial lung disease
R18	Subject_Disorder Arg1:T71 Arg2:T78	
R19	part_of Arg1:T37 Arg2:T71	
T72	Gene_expression 594 604	production
R20	part_of Arg1:T11 Arg2:T12	
R21	part_of Arg1:T98 Arg2:T12	
R22	part_of Arg1:T99 Arg2:T12	
N21	Reference E29 UMLS:C0017262	Gene Expression
N13	Reference E31 UMLS:C0017262	Gene Expression
N18	Reference E32 UMLS:C0017262	Gene Expression
N19	Reference E33 UMLS:C0017262	Gene Expression
N20	Reference E34 UMLS:C0017262	Gene Expression
N17	Reference E35 UMLS:C0017262	Gene Expression
N16	Reference E36 UMLS:C0017262	Gene Expression
N15	Reference E37 UMLS:C0017262	Gene Expression
N14	Reference E38 UMLS:C0017262	Gene Expression
A32	Speculated E42
A34	Speculated E46
A36	Speculated E45
A38	Speculated E44
A40	Speculated E43
A42	Speculated E41
A44	Speculated E40
A46	Speculated E30
A48	Speculated E39
R23	Disorder_association Arg1:T81 Arg2:T89	
N26	Reference E57 UMLS:C0017262	Gene Expression
T33	Gene_expression 1214 1224	production
T51	Gene_expression 1214 1224	production
T60	Gene_expression 1214 1224	production
N57	Reference E61 UMLS:C0017262	Gene Expression
N58	Reference E60 UMLS:C0017262	Gene Expression
N59	Reference E62 UMLS:C0017262	Gene Expression
N60	Reference E63 UMLS:C0017262	Gene Expression
E5	Gene_expression:T33 Theme:T74 atLoc:T27
N87	Reference E5 UMLS:C0017262	Gene Expression
E78	Gene_expression:T33 atLoc:T27 Theme:T74
T31	Gene_expression 1675 1685	production
T77	Gene_expression 1675 1685	production
T79	Gene_expression 1675 1685	production
N56	Reference E66 UMLS:C0017262	Gene Expression
N55	Reference E65 UMLS:C0017262	Gene Expression
N54	Reference E64 UMLS:C0017262	Gene Expression
N53	Reference E4 UMLS:C0017262	Gene Expression
A50	Organism_sbjct T71 Human
A51	Patient_sbjct T71 Patient
N94	Reference E22 UMLS:C0302600	Angiogenic Process
N64	Reference E19 UMLS:C1155266	inflammatory response
N99	Reference E78 UMLS:C0017262	Gene Expression
N100	Reference T113 UMLS:C0030705	Patients
T4	Anatomical_entity 96 100	lung
N86	Reference T4 UMLS:C0024109	Lung
N101	Reference E13 UMLS:C0036536	Process of secretion
N102	Reference E12 UMLS:C0036536	Process of secretion
N38	Reference E3 UMLS:C0036536	Process of secretion
N12	Reference E1 UMLS:C0036536	Process of secretion
N22	Reference E50 UMLS:C0036536	Process of secretion
N25	Reference E49 UMLS:C0036536	Process of secretion
T12	Anatomical_entity 753 775	bronchoalveolar lavage
N104	Reference T12 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T14	Subject 779 787	patients
A1	Organism_sbjct T14 Human
A2	Patient_sbjct T14 Patient
R1	Subject_Disorder Arg1:T14 Arg2:T43	
T24	Subject 779 787	patients
R2	Subject_Disorder Arg1:T24 Arg2:T76	
A3	Organism_sbjct T24 Human
A4	Patient_sbjct T24 Patient
T26	Subject 779 787	patients
R4	Subject_Disorder Arg1:T26 Arg2:T9	
A14	Organism_sbjct T26 Human
A15	Patient_sbjct T26 Patient
R6	part_of Arg1:T12 Arg2:T90	
N105	Reference T71 UMLS:C0030705	Patients
N106	Reference T14 UMLS:C0030705	Patients
N107	Reference T24 UMLS:C0030705	Patients
N109	Reference T26 UMLS:C0030705	Patients
N110	Reference T11 UMLS:C0030705	Patients
N111	Reference T98 UMLS:C0030705	Patients
N113	Reference T99 UMLS:C0030705	Patients
N114	Reference T56 UMLS:C0030705	Patients
